Blog

Investors interested in Automotive - Original Equipment stocks are likely familiar with Visteon (VC) and Atmus Filtration Technologies (ATMU). But which of these two stocks presents investors with

Investors interested in Technology Services stocks are likely familiar with Coursera (COUR) and Amplitude, Inc. (AMPL). But which of these two stocks presents investors with the better value

Several long-term technology trends are converging around embedded software, cybersecurity and intelligent connected systems, creating new opportunities for companies that provide the foundational

Palo Alto Networks PANW is using strategic partnerships to expand its AI security platform and address new cybersecurity challenges. Rapid adoption of AI by enterprises requires the need for better

Johnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for the expanded use of Tecvayli

Honda Motor Co., Ltd. HMC is converting a U.S. battery plant originally intended for electric vehicle (EV) production to manufacture batteries for AI data centers, per Nikkei as cited in a Seeking

Zacks Investment Research has recently initiated coverage of Vroom, Inc. VRM, assigning an "Underperform" recommendation to the company's shares. This bearish stance reflects significant concerns

Futu Holdings FUTU and Upstart Holdings UPST both sit in the fintech world, but they give investors exposure to very different stories. Futu is a digital brokerage and wealth management platform

Toyota Motor Corporation’s TM global vehicle sales declined for the fourth straight month in May, as weak demand in China and the Middle East dragged down overall performance.Worldwide sales fell

KLA Corporation KLAC is benefiting from a new wave of artificial intelligence (AI)-driven semiconductor investment and appears well positioned to continue outperforming the broader wafer fabrication

Zacks Investment Research has recently initiated coverage of Fusemachines Inc. FUSE with an Underperform recommendation, citing a combination of financial, operational, and competitive challenges

Investors in PTC Inc. PTC need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $230.00 Call had some of the highest implied

Acuity Inc. AYI shows how an established lighting company can become a broader industrial technology story. Demand is increasingly tied to intelligent buildings, connected controls and data-enabled

Analog Devices ADI has a strong cash flow profile supported by high gross margins, low capital intensity and disciplined capital allocation. During the first six months of fiscal 2026, the company

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $200.00 Call had some of the highest implied

AbbVie ABBV announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending approval for its blockbuster

Spyre Therapeutics SYRE has given investors a classic biotech dilemma. The pipeline is advancing, the cash balance is large and the stock has already moved sharply higher.

That also makes the

Alto Ingredients, Inc. ALTO is increasingly looking beyond ethanol and positioning carbon dioxide (CO2) as a higher-value growth opportunity that could strengthen its earnings mix over time. In its

Acuity Inc. AYI has given investors a stronger operating story after its fiscal third-quarter results, but that does not automatically make the stock a clear buy.The company has earnings support

Growing investment in mission-critical infrastructure, advanced manufacturing, power systems and data center development continues to create attractive opportunities across the engineering and

The TJX Companies, Inc.’s TJX HomeGoods banner is increasingly looking like more than just a complementary business within the retailer's portfolio. The chain is emerging as a meaningful earnings

Arm Holdings ARM is stepping up its ambitions in AI infrastructure with the Arm AGI CPU, a processor purpose-built for the emerging era of agentic AI workloads. The company believes the shift from

Spyre Therapeutics SYRE gives investors a focused view of how inflammatory bowel disease drug development is changing.

The company is not built around a single asset. It is pursuing long-acting

Investors in Verisk Analytics, Inc. VRSK need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $140.00 Call had some of the highest

Spyre Therapeutics SYRE has become a closely watched clinical-stage biotech stock as investors look ahead to a busy stretch of data readouts that could define the company’s next phase. The company